HeartSciences (HSCSW) Change in Accured Expenses (2021 - 2026)
HeartSciences (HSCSW) reported Change in Accured Expenses of $68179.0 for Q1 2026, up 333.05% on a YoY basis from $15744.0 in Q1 2025, and up 120.4% quarter-over-quarter from -$334208.0 in Q4 2025.
HeartSciences (HSCSW) Change in Accured Expenses (2021 - 2026) Analysis & Trends
HeartSciences has reported Change in Accured Expenses for 6 years, with the latest figure at $68179.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 333.05% year-over-year to $68179.0; the trailing twelve-month figure through Jan 2026 stood at $162008.0 (up 200.12% YoY), and the FY2025 full-year result was $16791.0, up 128.61% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $68179.0, up from -$334208.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $371484.0 in Q2 2022, with the low at -$477475.0 in Q3 2022.
- Historically, Change in Accured Expenses has averaged $12728.1 across 5 years, with a median of $15744.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 997.02% — and 2025, when it soared 472.92%.
- HeartSciences' Change in Accured Expenses stood at $247141.0 in 2022, then sank by 126.67% to -$65901.0 in 2023, then plunged by 227.11% to -$215566.0 in 2024, then slumped by 55.04% to -$334208.0 in 2025, then jumped by 120.4% to $68179.0 in 2026.
- The last three Change in Accured Expenses figures came in at $68179.0 (Q1 2026), -$334208.0 (Q4 2025), and $166718.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | HeartSciences | - | - | - | 68,179.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 68,179.00 |
| Jan 31, 2026 | 68,179.00 |
| Oct 31, 2025 | -334,208.00 |
| Oct 31, 2025 | -334,208.00 |
| Jul 31, 2025 | 166,718.00 |
| Jul 31, 2025 | 166,718.00 |
| Apr 30, 2025 | 261,319.00 |
| Apr 30, 2025 | 261,319.00 |
| Jan 31, 2025 | 15,744.00 |
| Jan 31, 2025 | 15,744.00 |
| Oct 31, 2024 | -215,566.00 |
| Oct 31, 2024 | -215,566.00 |
| Jul 31, 2024 | -44,706.00 |
| Jul 31, 2024 | -44,706.00 |
| Apr 30, 2024 | 82,718.00 |
| Apr 30, 2024 | 82,718.00 |
| Jan 31, 2024 | -103,237.00 |
| Jan 31, 2024 | -103,237.00 |
| Oct 31, 2023 | -65,901.00 |
| Oct 31, 2023 | -65,901.00 |